AAAAAA
Results:
1-16
|
Results: 16
Authors:
Regina, S
Colombat, P
Fimbel, B
Guerois, C
Gruel, Y
Citation: S. Regina et al., Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha, HAEMOPHILIA, 7(5), 2001, pp. 526-527
Authors:
Delahousse, B
Maillot, F
Gabriel, I
Schellenberg, F
Lamisse, F
Gruel, Y
Citation: B. Delahousse et al., Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics, BL COAG FIB, 12(1), 2001, pp. 59-66
Authors:
Jonville-Bera, A
Autret-Leca, E
Gruel, Y
Citation: A. Jonville-bera et al., Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch, N ENG J MED, 345(8), 2001, pp. 622-623
Authors:
Pouplard, C
Iochmann, S
Renard, B
Herault, O
Colombat, P
Amiral, J
Gruel, Y
Citation: C. Pouplard et al., Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia, BLOOD, 97(10), 2001, pp. 3300-3302
Authors:
Macchi, L
Sarfati, R
Guicheteau, H
Chamlian, V
Pourrat, O
Gruel, Y
Magnin, G
Brizard, A
Boinot, C
Citation: L. Macchi et al., Thromboembolic prophylaxis with danaparoid (Orgaran (R)) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease, CL APPL T-H, 6(4), 2000, pp. 187-189
Authors:
Aillaud, MF
Morange, P
Juhan, I
Bauters, A
Jude, B
Biron-Andreani, C
Daures, JP
Schved, JF
Pernod, G
Polac, B
Bridey, F
De Prost, D
Borg, JY
Saladin-Theron, C
Le Cam, V
Denninger, MH
Truchaud, F
Trossaert, M
Boinot, C
Sultan, Y
Delahousse, B
Fimbel, B
Gruel, Y
Houbouyan, L
Bihour, C
Vergnes, C
Dutrillaux, F
Lorenzini, JL
Julia, A
Deschamps, A
Favier, R
Freyburger, G
Trzeciak, MC
Berruyer, M
Doumergue, G
Gris, JC
Toulon, P
Montpied, G
Marques-Verdier, A
Lequerrec, A
Guerin, V
Massignon, D
Citation: Mf. Aillaud et al., Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study, BL COAG FIB, 11(6), 2000, pp. 511-518
Authors:
Gruel, Y
Citation: Y. Gruel, Antiphospholipid syndrome and heparin-induced thrombocytopenia: Update on similarities and differences, J AUTOIMMUN, 15(2), 2000, pp. 265-268
Authors:
Guilmot, JL
Diot, E
Gruel, Y
Citation: Jl. Guilmot et al., Contribution of platelet antiaggregates in the prevention of complicationsof atherothrombosis, PRESSE MED, 29(13), 2000, pp. 709-716
Authors:
Martin, L
Machet, L
Gironet, N
Pouplard, C
Gruel, Y
Vaillant, L
Citation: L. Martin et al., Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin, CONTACT DER, 42(5), 2000, pp. 295-296
Authors:
Khalfoun, B
Barrat, D
Watier, H
Machet, MC
Arbeille-Brassart, B
Riess, JG
Salmon, H
Gruel, Y
Bardos, P
Lebranchu, Y
Citation: B. Khalfoun et al., Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions, SURGERY, 128(3), 2000, pp. 447-457
Authors:
Amiral, J
Pouplard, C
Vissac, AM
Walenga, JM
Jeske, W
Gruel, Y
Citation: J. Amiral et al., Affinity purification of heparin-dependent antibodies to platelet factor 4developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation, BR J HAEM, 109(2), 2000, pp. 336-341
Authors:
Pouplard, C
Amiral, J
Borg, JY
Laporte-Simitsidis, S
Delahousse, B
Gruel, Y
Citation: C. Pouplard et al., Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia, AM J CLIN P, 111(5), 1999, pp. 700-706
Authors:
Iochmann, S
Reverdiau-Moalic, P
Beaujean, S
Rideau, E
Lebranchu, Y
Bardos, P
Gruel, Y
Citation: S. Iochmann et al., Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription polymerase chain reaction, THROMB RES, 94(3), 1999, pp. 165-173
Authors:
Pouplard, C
May, MA
Iochmann, S
Amiral, J
Vissac, AM
Marchand, M
Gruel, Y
Citation: C. Pouplard et al., Antibodies to platelet factor 4 - Heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin - Clinical implications for heparin-induced thrombocytopenia, CIRCULATION, 99(19), 1999, pp. 2530-2536
Authors:
Martin, L
Machet, L
Michalak, S
Delahousse, B
Gruel, Y
Vaillant, L
Lorette, G
Citation: L. Martin et al., Acroangiodermatitis in a carrier of the thrombophilic 20210A mutation in the prothrombin gene, BR J DERM, 141(4), 1999, pp. 752-752
Authors:
Reverdiau-Moalic, P
Watier, H
Iochmann, S
Pouplard, C
Rideau, E
Lebranchu, Y
Bardos, P
Gruel, Y
Citation: P. Reverdiau-moalic et al., Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathway, J LA CL MED, 132(6), 1998, pp. 530-540
Risultati:
1-16
|